The Texas Children’s Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part II: Tactics - 05/09/11
, LAWRENCE L. GREENHILL, M.D., M. LYNN CRISMON, Pharm.D., ANDREW SEDILLO, M.D., CARYN CARLSON, PH.D., C. KEITH CONNERS, PH.D., JAMES T. McCRACKEN, M.D., JAMES M. SWANSON, PH.D., CARROLL W. HUGHES, PH.D., MARIA E. LLANA, Pharm.D., MOLLY LOPEZ, PH.D., MARCIA G. TOPRAC, PH.D.THE TEXAS CONSENSUS CONFERENCE PANEL ON MEDICATION TREATMENT OF CHILDHOOD ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
ABSTRACT |
Objectives |
Expert consensus methodology was used to develop a medication treatment algorithm for attention-deficit/hyperactivity disorder (ADHD). The algorithm broadly outlined the choice of medication for ADHD and some of its most common comorbid conditions. Specific tactical recommendations were developed with regard to medication dosage, assessment of drug response, management of side effects, and long-term medication management.
Method |
The consensus conference of academic clinicians and researchers, practicing clinicians, administrators, consumers, and families developed evidence-based tactics for the pharmacotherapy of childhood ADHD and its common comorbid disorders. The panel discussed specifics of treatment of ADHD and its comorbid conditions with stimulants, antidepressants, mood stabilizers, ⍺-agonists, and (when appropriate) antipsychotics.
Results |
Specific tactics for the use of each of the above agents are outlined. The tactics are designed to be practical for implementation in the public mental health sector, but they may have utility in many practice settings, including the private practice environment.
Conclusions |
Tactics for psychopharmacological management of ADHD can be developed with consensus.
Le texte complet de cet article est disponible en PDF.Key Words : attention-deficit/hyperactivity disorder, algorithm, psychopharmacology, practice parameters
Plan
| Consensus Conference Panel members and their affiliations are listed before the references. This consensus conference was funded by a grant from the Meadows Foundation, Dallas. Members of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder: Caryn Carlson, Ph.D., Department of Psychology, The University of Texas at Austin; C. Keith Conners, Ph.D., Department of Psychiatric and Behavioral Science, Duke University, Durham, NC; M. Lynn Crismon, Pharm.D. (co-chair), College of Pharmacy, The University of Texas at Austin; Lawrence L. Greenhill, M.D., New York State Psychiatric Institute, New York; James T. McCracken, M.D., UCLA Neuropsychiatric Institute, Los Angeles; Robin Moir, M.D., Andrews MHMR Center, Amarillo, TX; William Porcher, M.D., Bluebonnet Trails MHMR Center, Round Rock, TX; Mario Quintanilla, M.D., Nueces County MHMR Center, Corpus Christi, TX; Steven R. Pliszka, M.D. (chair), Department of Psychiatry, University of Texas Health Science Center at San Antonio; Linda Rhodes, M.D., Department of Psychiatry, University of Texas Health Science Center at San Antonio; S. Rogers, family member, Dallas; M. Serna, family member, San Antonio; Cynthia Santos, M.D., Department of Psychiatry, University of Texas Health Science Center at Houston; Beverly Sutton, M.D., Residency Training, Austin State Hospital, Austin, TX; James M. Swanson, Ph.D., Department of Psychiatry, University of California at Irvine; James Terfructe, M.D., private practice and Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas. Members Ex-Officio: Carroll W. Hughes, Ph.D., Psychology Department, Terrell State Hospital, Terrell, TX; Maria E. Llana, Pharm.D., Department of Psychiatry, Scott and White Hospital and Clinic, Temple, TX; Molly Lopez, Ph.D., Texas Department of Mental Health and Mental Retardation, Austin; Nancy MacCabe, Ph.D., Texas Department of Mental Health and Mental Retardation, Austin; Andrew Sedillo, M.D., Texas Department of Mental Health and Mental Retardation, Austin; Sharon Sheldon, Texas Department of Mental Health and Mental Retardation, Austin; Steven P. Shon, M.D., Texas Department of Mental Health and Mental Retardation, Austin; Marcia G. Toprac, Ph.D., Texas Department of Mental Health and Mental Retardation, Austin; Madhukar Trivedi, Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas. |
Vol 39 - N° 7
P. 920-927 - juillet 2000 Retour au numéro
Article précédent
- The Texas Children’s Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part I
- STEVEN R. PLISZKA, LAWRENCE L. GREENHILL, M. LYNN CRISMON, ANDREW SEDILLO, CARYN CARLSON, C. KEITH CONNERS, JAMES T. McCRACKEN, JAMES M. SWANSON, CARROLL W. HUGHES, MARIA E. LLANA, MOLLY LOPEZ, MARCIA G. TOPRAC, THE TEXAS CONSENSUS CONFERENCE PANEL ON MEDICATION TREATMENT OF CHILDHOOD ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
- Evaluating and Reporting Emotional Abuse in Children: Parent-Based, Action-Based Focus Aids in Clinical Decision-Making
- STEPHANIE HAMARMAN, WILLIAM BERNET
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?